Prudential Financial Inc Fate Therapeutics Inc Transaction History

Prudential Financial Inc

  • $65.9 Billion
  • Q2 2024

A detailed history of Prudential Financial Inc transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Prudential Financial Inc holds 356,101 shares of FATE stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
356,101
Previous 383,201 7.07%
Holding current value
$1.27 Million
Previous $2.81 Million 58.46%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$3.26 - $7.08 $88,346 - $191,868
-27,100 Reduced 7.07%
356,101 $1.17 Million
Q1 2024

May 14, 2024
SELL
$3.54 - $8.35 $625,907 - $1.48 Million
-176,810 Reduced 31.57%
383,201 $2.81 Million
Q4 2023

Feb 13, 2024
BUY
$1.65 - $3.94 $602,415 - $1.44 Million
365,100 Added 187.32%
560,011 $2.09 Million
Q3 2023

Nov 13, 2023
BUY
$2.02 - $5.04 $259,772 - $648,144
128,600 Added 193.93%
194,911 $413,000
Q2 2023

Aug 11, 2023
SELL
$4.76 - $6.59 $445,536 - $616,824
-93,600 Reduced 58.53%
66,311 $315,000
Q1 2023

May 12, 2023
BUY
$4.24 - $11.12 $678,022 - $1.78 Million
159,911 New
159,911 $911,000
Q2 2022

Aug 15, 2022
SELL
$17.78 - $42.39 $120,299 - $286,810
-6,766 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$29.67 - $60.28 $1,839 - $3,737
-62 Reduced 0.91%
6,766 $262,000
Q4 2021

Feb 14, 2022
SELL
$47.84 - $64.34 $3.17 Million - $4.26 Million
-66,188 Reduced 90.65%
6,828 $408,000
Q3 2021

Nov 15, 2021
SELL
$59.27 - $95.73 $89,734 - $144,935
-1,514 Reduced 2.03%
73,016 $4.42 Million
Q2 2021

Aug 16, 2021
BUY
$67.25 - $92.52 $642,573 - $884,028
9,555 Added 14.71%
74,530 $6.47 Million
Q1 2021

May 12, 2021
SELL
$72.16 - $117.4 $292,464 - $475,822
-4,053 Reduced 5.87%
64,975 $5.36 Million
Q4 2020

Feb 16, 2021
BUY
$38.09 - $100.95 $556,990 - $1.48 Million
14,623 Added 26.88%
69,028 $6.28 Million
Q3 2020

Nov 16, 2020
SELL
$30.41 - $40.5 $80,890 - $107,730
-2,660 Reduced 4.66%
54,405 $2.18 Million
Q2 2020

Aug 12, 2020
SELL
$20.21 - $35.23 $400,036 - $697,342
-19,794 Reduced 25.75%
57,065 $1.96 Million
Q1 2020

May 12, 2020
BUY
$17.28 - $31.88 $3,801 - $7,013
220 Added 0.29%
76,859 $1.71 Million
Q4 2019

Feb 11, 2020
BUY
$13.39 - $20.73 $1.03 Million - $1.59 Million
76,639 New
76,639 $1.5 Million

Others Institutions Holding FATE

# of Institutions
190
Shares Held
123M
Call Options Held
15K
Put Options Held
14K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $346M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email